🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to examine the effect of GLP-1 and other gut-secre...
Status
Completed
Location
Hvidovre University Hospital
Start Date
2014-04
Trial ID
NCT02336659
Treatments Being Tested
This is a randomized, controlled clinical trial with a two-sided superiorit...
Status
Recruiting
Location
Dexeus Mujer Sabadell
Start Date
2026-01-19
Trial ID
NCT07242534
Treatments Being Tested
To determine the extent to which the effects of treatment with LAF237 100 m...
Status
Completed
Location
Diabeteszentrum Bad Lauterberg
Start Date
2008-02
Trial ID
NCT02639130
Treatments Being Tested
The aim of this study is to investigate if endogenous Glucagon Like Peptide...
Status
Completed
Location
VU University Medical Center
Start Date
2011-10
Trial ID
NCT01363609
Treatments Being Tested
AVX-001 (LUCIDITY) is a Phase 3 study to evaluate avexitide compared to pla...
Status
Active Not Recruiting
Location
Stanford Health Care - Endocrinology Clinic
Start Date
2025-04-29
Trial ID
NCT06747468
This study will describe the interplay between the gut hormones GIP and CCK...
Status
Recruiting
Location
Rigshospitalet
Start Date
2025-03-15
Trial ID
NCT07019519
Treatments Being Tested
Delinieation of GIP's effects during an oral glucose tolerance test (OGTT) ...
Status
Completed
Location
Center for Diabetes Research
Start Date
2017-03-01
Trial ID
NCT03133741
Treatments Being Tested
This study will investigating the effects of glucagon on renal blood flow i...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-01
Trial ID
NCT06872060
Treatments Being Tested
The purpose of this study is to explore the mechanisms of metabolic control...
Status
Completed
Location
University of Chicago
Start Date
2014-01
Trial ID
NCT01795144
Treatments Being Tested
Glucagon secretion from α-cells has long been viewed as primarily a counter...
Status
Recruiting
Location
Duke Center for Living
Start Date
2025-12-30
Trial ID
NCT07224334